Results 81 to 90 of about 17,628 (210)
ABSTRACT Cervical carcinosarcoma (CCS), also known as malignant mixed Müllerian tumor (MMMT) of the cervix, is an exceptionally rare and aggressive biphasic neoplasm composed of both epithelial and mesenchymal malignant components. Due to its rarity, optimal management strategies are not well established, particularly in low‐resource settings.
John Lugata +11 more
wiley +1 more source
PURPOSE This study was undertaken to assess the ability of computed tomography (CT) to predict the likelihood of optimal primary tumor cytoreduction in women with epithelial ovarian carcinoma. PATIENTS AND METHODS Fifty-one women with preoperative CT and
P E Schwartz, A T Rosenfield, B E Nelson
core +1 more source
Colorectal cancer is a heterogeneous, adaptive disease shaped by population‐level risk, genomic and epigenetic alterations, tumor ecosystem evolution, and treatment pressure. This review integrates epidemiology, risk factors, signaling networks, clinical presentation, screening, molecular diagnosis, and stage‐ and biomarker‐guided management while ...
Kairui Wan +6 more
wiley +1 more source
KRAS Mutations in Cancers: From Undruggable Dilemma to Precision Medicine
KRAS‐mutant cancers are therapeutically shaped by both allele identity and tumor context. Direct KRAS inhibition has achieved the greatest clinical success in KRAS G12C‐mutant NSCLC, whereas colorectal cancer often requires EGFR cotargeting and pancreatic cancer remains constrained by stromal and metabolic barriers. Shared resistance mechanisms include
Jiaying Cai +18 more
wiley +1 more source
Intra-thoracic cytoreduction of stage IV peritoneal malignancy: A case series
Women with ovarian cancer primarily present with advanced intra-abdominal disease, frequently involving the diaphragm. We present 2 cases of combined planned intra-thoracic and abdominopelvic radical cytoreduction for stage IV peritoneal malignancy.
Levine, Douglas A +4 more
core +1 more source
Long term survivors beyond tertiary cytoreduction for relapsed ovarian cancer [PDF]
Universitatea de Medicină și Farmacie “Carol Davila”, Spitalul “Ponderas”, Departamentul de Chirurgie Generală și Transplant Hepatic “Dan Setlacec”, Institutul Clinic Fundeni, Bucureşti, România.
Dima, S. +4 more
core +1 more source
Differentiating high‐ and low‐grade serous ovarian carcinoma using radiomics: a pilot study
ABSTRACT Objective To identify ultrasound‐based radiomics features capable of distinguishing between high‐grade serous ovarian carcinomas (HGSC) and invasive low‐grade serous ovarian carcinomas (LGSC), and to develop machine‐learning models that include radiomics features to discriminate between the two.
F. Ciccarone +18 more
wiley +1 more source
Objective. The aim of this study was to investigate the predictive value of serum CA-125 levels to ability of optimal primary cytoreduction in patients with advanced epithelial ovarian ...
Erten, O +11 more
core +1 more source
Summary Over the past decade, there has been a substantial increase in the diversity and number of therapeutic options for myeloproliferative neoplasms (MPNs). While many remain within the clinical trial arena, the clinician and patient community have seen more approvals reaching the clinic and a rethink on how best we should be approaching these ...
Trung Q. Ngo +3 more
wiley +1 more source
Computed tomography; Cytoreductive surgery; Optimal cytoreduction; Ovarian cancer; Spread pattern; Surgical skill ...
김승철
core +1 more source

